Of the things the 2025 BMW M4 needed, more power wasn’t one of them.Not every version of M’s middleweight bruiser gets the ...

In November 2024, the Centers for Medicare & Medicaid Services (“CMS”) released a final rule addressing, among other things, the Medicare Parts A ...

This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

4 At baseline, the questionnaire completion rates were ≥90% and remained high (≥85%) up to week 205. The baseline patient-reported outcome scores indicated low levels of pain and high health-related ...